glp 1 and biologics DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model GLP-1 for Weight Loss and

It is widely studied in laboratory environments for its role in cellular signaling and tissue response pathways

Biologic therapies, such as anti-TNF- monoclonal antibody and JAK inhibitor, primarily consist of small molecules targeting specific pathways, effectively inducing and maintaining remission

High levels of LC can increase arterial oxygen saturation, reduce COVID-19 severity, and accelerate recovery probably by reducing the expression of the angiotensin-converting enzyme 2 receptors and inhibiting the binding of the virus to the lung cells []

Mousavi A, Shojaei S, Soleimani H, Semirani-Nezhad D, Ebrahimi P, Zafari A, et al